Skip to content
  • Debatforum
  • Seneste
  • Populære
  • Bruger
Temaer
  • Light
  • Dark

Kollaps
FORSIDEN
Log ind Opret konto

Genmab — Juli 2018

Planlagt Fastgjort Låst Flyttet Genmab
1.3k Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • G Offline
    G Offline
    gentogen
    wrote on sidst redigeret af
    #879

    blocking CD38 expression improved tumor control even when using Th0 anti-tumor T cells. Thus, strategies targeting the CD38-NAD+ axis could increase the efficacy of anti-tumor adoptive T cell therapy.

    1 Reply Last reply
    0
    • G Offline
      G Offline
      gentogen
      wrote on sidst redigeret af
      #880

      https://www.ncbi.nlm.nih.gov/pubmed/29129787

      1 Reply Last reply
      0
      • G Offline
        G Offline
        gentogen
        wrote on sidst redigeret af
        #881

        Invalid URL

        favicon

        (musc.technologypublisher.com)

        1 Reply Last reply
        0
        • G Offline
          G Offline
          gentogen
          wrote on sidst redigeret af
          #882

          The invention will potentially result in cost effective and less complex treatment, ultimately, allowing the widespread application of ACT.

          1 Reply Last reply
          0
          • G Offline
            G Offline
            gentogen
            wrote on sidst redigeret af
            #883

            Ikke at jeg vil påstå at jeg forstår det....

            1 Reply Last reply
            0
            • E Offline
              E Offline
              E_L
              wrote on sidst redigeret af
              #884

              😉

              1 Reply Last reply
              0
              • BulderB Offline
                BulderB Offline
                Bulder
                wrote on sidst redigeret af
                #885

                act, her udtager man også t-celler og fremstiller i laboratoriet en hybridform af to t-celle-undertyper - Th1 og Th17 - som kombinerer de cancerbekæmpende egnskaber ved Th1-cellerne med evnen hos Th17 til at forny sig selv og regenermere, og som sammen med et cd-38 antistof kan angribe tumorer mere effektivt.

                1 Reply Last reply
                0
                • BulderB Offline
                  BulderB Offline
                  Bulder
                  wrote on sidst redigeret af
                  #886

                  Ovenstående fandt jeg i mine noter.

                  1 Reply Last reply
                  0
                  • BulderB Offline
                    BulderB Offline
                    Bulder
                    wrote on sidst redigeret af
                    #887

                    Det er en slags variant af car-t.

                    1 Reply Last reply
                    0
                    • BulderB Offline
                      BulderB Offline
                      Bulder
                      wrote on sidst redigeret af
                      #888

                      Regenerere skal der stå

                      1 Reply Last reply
                      0
                      • BulderB Offline
                        BulderB Offline
                        Bulder
                        wrote on sidst redigeret af
                        #889

                        Immatics, som Genmab netop har indledt samarbejde med, har en del på bedding inden for ACT i samarbejde med MD Anderson. https://immatics.com/act.html

                        1 Reply Last reply
                        0
                        • Helge_LarsenPI-redaktørH Offline
                          Helge_LarsenPI-redaktørH Offline
                          Helge_LarsenPI-redaktør
                          wrote on sidst redigeret af
                          #890

                          Just a moment...

                          favicon

                          (www.proinvestor.com)

                          1 Reply Last reply
                          0
                          • B Offline
                            B Offline
                            Bella1
                            wrote on sidst redigeret af
                            #891

                            Fornemt og fortjent selskab! 🙂

                            1 Reply Last reply
                            0
                            • G Offline
                              G Offline
                              GeorgeBest
                              wrote on sidst redigeret af
                              #892

                              Fin artikel om dara sc og amyloidosis (ANDROMEDA studiet) https://www.raredr.com/news/ray-comenzo-md-discusses-andromeda-trial-al-amyloidosis-patients

                              1 Reply Last reply
                              0
                              • Helge_LarsenPI-redaktørH Offline
                                Helge_LarsenPI-redaktørH Offline
                                Helge_LarsenPI-redaktør
                                wrote on sidst redigeret af
                                #893

                                "
                                The response rates were really stunning even though these patients in the ramp-in didn’t go through the entire course of therapy before the responses were scored. They are still getting treated, obviously, but three-quarters of patients recorded very deep responses"

                                1 Reply Last reply
                                0
                                • Helge_LarsenPI-redaktørH Offline
                                  Helge_LarsenPI-redaktørH Offline
                                  Helge_LarsenPI-redaktør
                                  wrote on sidst redigeret af
                                  #894

                                  "If daratumumab and CyBorD works better than CyBorD alone, we have a new standard of therapy for patients with light chain amyloidosis. In addition, the study is designed to allow patients to have their blood stem cells collected after 6 months of treatment"
                                  .

                                  1 Reply Last reply
                                  0
                                  • Helge_LarsenPI-redaktørH Offline
                                    Helge_LarsenPI-redaktørH Offline
                                    Helge_LarsenPI-redaktør
                                    wrote on sidst redigeret af
                                    #895

                                    Tak for link GB. 🙂

                                    1 Reply Last reply
                                    0
                                    • Don_JoningD Offline
                                      Don_JoningD Offline
                                      Don_Joning
                                      wrote on sidst redigeret af
                                      #896

                                      den bed jeg også mærke i Helge 15.45 + "... 2 dozen patients were treated in the ramp-in, there was no safety problems with the subcutaneous daratumumab, and all of the 2 dozen patients received daratumumab with CyBorD.".

                                      1 Reply Last reply
                                      0
                                      • J Offline
                                        J Offline
                                        JKY_VH
                                        wrote on sidst redigeret af
                                        #897

                                        Er der nogen der ved, hvor mange der er ramt af amyloidosis?

                                        1 Reply Last reply
                                        0
                                        • Don_JoningD Offline
                                          Don_JoningD Offline
                                          Don_Joning
                                          wrote on sidst redigeret af
                                          #898

                                          5/7 15:46
                                          af gentogen
                                          It is estimated that there are 12,000 adults in the United States currently living with AL amyloidosis. (Blood Cancer Journalvolume 8, Article number: 44 (2018)

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind

                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          • First post
                                            Last post
                                          0
                                          • Debatforum
                                          • Seneste
                                          • Populære
                                          • Bruger